Learn More
Description
Specifications
Specifications
| Antigen | TPX2 |
| Applications | Western Blot, Immunocytochemistry, Immunofluorescence, Immunoprecipitation, Immunohistochemistry (Paraffin) |
| Classification | Polyclonal |
| Concentration | 1.0 mg/mL |
| Conjugate | Unconjugated |
| Dilution | Western Blot 1:5000-1:15000, Immunocytochemistry/Immunofluorescence 1:250 to 1:1000, Immunoprecipitation 1-4 ug/mg lysate |
| Formulation | Tris-Citrate/Phosphate (pH 7.0 - 8.0) with 0.09% Sodium Azide |
| Gene Accession No. | Q9ULW0 |
| Gene Alias | C20orf1HCTP4, C20orf2, chromosome 20 open reading frame 1, Differentially expressed in cancerous and non-cancerous lung cells 2, differentially expressed in lung cells, DIL2, DIL-2FLS353, HCA519, Hepatocellular carcinoma-associated antigen 519, P100, p100GD:C20orf1, preferentially expressed in colorectal cancer, Protein fls353, REPP86, restricted expression proliferation associated protein 100, Restricted expression proliferation-associated protein 100, targeting protein for Xklp2, TPX2, microtubule-associated protein homolog, TPX2, microtubule-associated, homolog (Xenopus laevis) |
| Gene Symbols | TPX2 |
| Show More |
For Research Use Only
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
